Adrián LLerena (Adrián Llerena, Adrian Llerena)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 27

Top Venues

Drug metabolism and personalized therapy

Pharmacogenomics

The pharmacogenomics journal

Pharmacopsychiatry

Extremadura University Hospital and Medical School

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Extremadura University Hospital and Medical School Jan 01 2006

Spain

Director/ Professor :: CICAB Clinical Research Center

Publications

María Estévez-Paredes, M Carmen Mata-Martín, Fernando de Andrés, Adrián LLerena
Pharmacogenomic biomarker information on drug labels of the Spanish Agency of Medicines and Sanitary products: evaluation and comparison with other regulatory agencies. The pharmacogenomics journal 24 (1) (2024)
María Estévez-Paredes, M Carmen Mata-Martín, Fernando de Andrés, Adrián LLerena
Pharmacogenomic biomarker information on drug labels of the Spanish Agency of Medicines and Sanitary products: evaluation and comparison with other regulatory agencies. The pharmacogenomics journal 24 (1) (2024)
María Estévez-Paredes, M Carmen Mata-Martín, Fernando de Andrés, Adrián LLerena
Pharmacogenomic biomarker information on drug labels of the Spanish Agency of Medicines and Sanitary products: evaluation and comparison with other regulatory agencies. The pharmacogenomics journal 24 (1) (2024)
Ingrid Fricke-Galindo, Adrián LLerena
News in DMPT: Leaders in Pharmacogenetics Section. Drug metabolism and personalized therapy 38 (1) (2023)
Martha Sosa-Macias, Ingrid Fricke-Galindo, Humberto Fariñas, Lucero Monterde, Eugenia Dolores Ruiz-Cruz, Juan Arcadio Molina-Guarneros, Eduardo Martín Tarazona Santos, Fernanda Rodrigues-Soares, Carlos Galaviz-Hernández, Eva M Peñas-Lledó, Graciela Moya, Julio Lara-Riegos, Enrique Terán, Isabel Hernández, Ronald Ramírez-Roa, Catalina Altamirano-Tinoco, Marisol López-López, José Elías García-Ortiz, Adrián LLerena
Pharmacogenetics: ethnicity, treatment and health in Latin American populations. Pharmacogenomics (2023)
Ingrid Fricke-Galindo, Adrián LLerena
News in DMPT: Leaders in Pharmacogenetics Section. Drug metabolism and personalized therapy 38 (1) (2023)
Ingrid Fricke-Galindo, Adrián LLerena
News in DMPT: Leaders in Pharmacogenetics Section. Drug metabolism and personalized therapy 38 (1) (2023)
Ingrid Fricke-Galindo, Adrián LLerena
Ancestromics. Drug metabolism and personalized therapy 38 (4) (2023)
Ingrid Fricke-Galindo, Adrián LLerena
Ancestromics. Drug metabolism and personalized therapy 38 (4) (2023)
Francisco C Ceballos, Eugenio Chamizo-Carmona, Carmen Mata-Martín, Carmen Carrasco-Cubero, Juan J Aznar-Sánchez, Raúl Veroz-González, Sara Rojas-Herrera, Pedro Dorado, Adrián LLerena
Pharmacogenetic Sex-Specific Effects of Methotrexate Response in Patients with Rheumatoid Arthritis. Pharmaceutics 15 (6) (2023)
Ingrid Fricke-Galindo, Adrián LLerena
Relevance of personalized medicine for improving traditional medicine. Drug metabolism and personalized therapy 38 (3) (2023)
Ron H N van Schaik, Vangelis G Manolopoulos, Ann K Daly, Mikko Niemi, Branka Zukic, George P Patrinos, Dragan Primorac, Jesse Joachim Swen, Magnus Ingelman-Sundberg, Tiffany Morris, Espen Molden, Daniel Müller, Sonja Pavlovic, Stefan Russmann, Marc Ansari, Linda M Henricks, Wout van den Broek, Francesco Florindi, Nada Bozina, Demet Akin, Lona Christrup, Adrián LLerena, Cilla Sipeky, Sanja Stankovic
The Sixth European Society of Pharmacogenomics and Personalised Therapy Congress (Belgrade, 8-9 November 2022). Pharmacogenomics (2023)
Ingrid Fricke-Galindo, Adrián LLerena
Pharmacogenetics and ethnicity: "Dr. José María Cantú" award announcement. Drug metabolism and personalized therapy (2023)
Francisco C Ceballos, Eugenio Chamizo-Carmona, Carmen Mata-Martín, Carmen Carrasco-Cubero, Juan J Aznar-Sánchez, Raúl Veroz-González, Sara Rojas-Herrera, Pedro Dorado, Adrián LLerena
Pharmacogenetic Sex-Specific Effects of Methotrexate Response in Patients with Rheumatoid Arthritis. Pharmaceutics 15 (6) (2023)
Ingrid Fricke-Galindo, Adrián LLerena
News in DMPT: Leaders in Pharmacogenetics Section. Drug metabolism and personalized therapy (2023)
Ingrid Fricke-Galindo, Adrián LLerena
Relevance of personalized medicine for improving traditional medicine. Drug metabolism and personalized therapy (2023)
Ingrid Fricke-Galindo, Adrián LLerena
News in DMPT: Leaders in Pharmacogenetics Section. Drug metabolism and personalized therapy 38 (1) (2023)
Ingrid Fricke-Galindo, Adrián LLerena
Ancestromics. Drug metabolism and personalized therapy (2023)
Jose De Leon, Georgios Schoretsanitis, Robert Løvsletten Smith, Espen Molden, Anssi Solismaa, Niko Seppälä, Miloslav Kopeček, Patrik Švancer, Ismael Olmos, Carina Ricciardi, Celso Iglesias-Garcia, Ana Iglesias-Alonso, Edoardo Spina, Can-Jun Ruan, Chuan-Yue Wang, Gang Wang, Yi-Lang Tang, Shih Ku Lin, Hsien-Yuan Lane, Yong Sik Kim, Se Hyun Kim, Anto P Rajkumar, Dinora Fabiola González Esquivel, Helgi Jung-Cook, Trino Baptista, Christopher Rohde, Jimmi Nielsen, Hélène Verdoux, Clelia Quiles, Emílio J Sanz, Carlos de Las Cuevas, Dan Cohen, Peter F J Schulte, Aygün Ertuğrul, Elif Anıl Yağcıoğlu, Nitin Chopra, Betsy McCollum, Charles Shelton, Robert O Cotes, Arun R Kaithi, John M Kane, Saeed Farooq, Chee H Ng, John Bilbily, Christoph Hiemke, Carlos López-Jaramillo, Ian R McGrane, Fernando Lana, Chin Bin Eap, Manuel Arrojo-Romero, Flavian Ş Rădulescu, Erich Seifritz, Susanna Every-Palmer, Chad A Bousman, Emmanuel Bebawi, Rahul Bhattacharya, Deanna L Kelly, Yuji Otsuka, Judit Lazary, Rafael Torres, Agustin Yecora, Mariano Motuca, Kit Wa Sherry Chan, Monica Zolezzi, Sami Ouanes, Domenico de Berardis, Sandeep Grover, Ric M Procyshyn, Richard A Adebayo, Oleg O Kirilochev, Andrey Soloviev, Konstantinos N Fountoulakis, Alina Wilkowska, Wiesław Jerzy Cubała, Muhammad Ayub, Alzira Silva, Raphael M Bonelli, Jose M Villagrán-Moreno, Jacqueline Mayoral-van Son, Henk S Temmingh, Eric H Decloedt, Maria R Pedro, Hiroyoshi Takeuchi, Masaru Tsukahara, Gerhard Gründer, Marina Šagud, Andreja Celofiga, Dragana Ignjatovic Ristic, Bruno B Ortiz, Helio Elkis, Antônio Pacheco Palha, Adrián LLerena, Emilio Fernandez-Egea, Dan J Siskind, Abraham Weizman, Rim Masmoudi, Shamin Mohd Saffian, Jonathan G Leung, Peter F Buckley, Stephen R Marder, Citrome Leslie, Oliver Freudenreich, Christoph U Correll, Daniel J Mueller
Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels. Pharmacopsychiatry 55 (2) (2022)
Eva M Peñas-Lledó, Sebastien Guillaume, Fernando de Andrés, Ana Cortés-Martínez, Jonathan Dubois, Jean Pierre Kahn, Marion Leboyer, Emilie Olié, Adrián LLerena, Philippe Courtet
A one-year follow-up study of treatment-compliant suicide attempt survivors: relationship of CYP2D6-CYP2C19 and polypharmacy with suicide reattempts. Translational psychiatry 12 (1) (2022)
Sabrina Torres-Loureiro, Mariana Meira Scudeler, Poliana Xc Andrade, Julia Sampaio-Coelho, Igor H Nobre, Carolina Céspedes-Garro, Eduardo Martín Tarazona Santos, Adrián LLerena, Fernanda Rodrigues-Soares
Pharmacogenetics research in Brazil: a systematic review. Pharmacogenomics 23 (4) (2022)
Ingrid Fricke-Galindo, Helgi Jung-Cook, Iris E Martínez-Juárez, Nancy Monroy-Jaramillo, Alberto Ortega-Vázquez, Irma S Rojas-Tomé, Pedro Dorado, Eva M Peñas-Lledó, Adrián LLerena, Marisol López-López
Relevance of NR1I2 variants on carbamazepine therapy in Mexican Mestizos with epilepsy at a tertiary-care hospital. Pharmacogenomics 22 (15) (2021)
Jose De Leon, Georgios Schoretsanitis, Robert Løvsletten Smith, Espen Molden, Anssi Solismaa, Niko Seppälä, Miloslav Kopeček, Patrik Švancer, Ismael Olmos, Carina Ricciardi, Celso Iglesias-Garcia, Ana Iglesias-Alonso, Edoardo Spina, Can-Jun Ruan, Chuan-Yue Wang, Gang Wang, Yi-Lang Tang, Shih Ku Lin, Hsien-Yuan Lane, Yong Sik Kim, Se Hyun Kim, Anto P Rajkumar, Dinora Fabiola González Esquivel, Helgi Jung-Cook, Trino Baptista, Christopher Rohde, Jimmi Nielsen, Hélène Verdoux, Clelia Quiles, Emílio J Sanz, Carlos de Las Cuevas, Dan Cohen, Peter F J Schulte, Aygün Ertuğrul, Elif Anıl Yağcıoğlu, Nitin Chopra, Betsy McCollum, Charles Shelton, Robert O Cotes, Arun R Kaithi, John M Kane, Saeed Farooq, Chee H Ng, John Bilbily, Christoph Hiemke, Carlos López-Jaramillo, Ian R McGrane, Fernando Lana, Chin Bin Eap, Manuel Arrojo-Romero, Flavian Ş Rădulescu, Erich Seifritz, Susanna Every-Palmer, Chad A Bousman, Emmanuel Bebawi, Rahul Bhattacharya, Deanna L Kelly, Yuji Otsuka, Judit Lazary, Rafael Torres, Agustin Yecora, Mariano Motuca, Kit Wa Sherry Chan, Monica Zolezzi, Sami Ouanes, Domenico de Berardis, Sandeep Grover, Ric M Procyshyn, Richard A Adebayo, Oleg O Kirilochev, Andrey Soloviev, Konstantinos N Fountoulakis, Alina Wilkowska, Wiesław Jerzy Cubała, Muhammad Ayub, Alzira Silva, Raphael M Bonelli, Jose M Villagrán-Moreno, Jacqueline Mayoral-van Son, Henk S Temmingh, Eric H Decloedt, Maria R Pedro, Hiroyoshi Takeuchi, Masaru Tsukahara, Gerhard Gründer, Marina Šagud, Andreja Celofiga, Dragana Ignjatovic Ristic, Bruno B Ortiz, Helio Elkis, Antônio Pacheco Palha, Adrián LLerena, Emilio Fernandez-Egea, Dan J Siskind, Abraham Weizman, Rim Masmoudi, Shamin Mohd Saffian, Jonathan G Leung, Peter F Buckley, Stephen R Marder, Citrome Leslie, Oliver Freudenreich, Christoph U Correll, Daniel J Mueller
An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels. Pharmacopsychiatry 55 (2) (2021)
Miquel Taron, Adrián LLerena, Vangelis G Manolopoulos, Cristina Rodriguez-Antona, Sanja Stankovic, Ron H N van Schaik
The need of the clinical implementation of pharmacogenetics in European health services for routine drug prescription. What's next? An urgent clinical unmet need for patients. Drug metabolism and personalized therapy 35 (4) (2020)
Miquel Taron, Adrián LLerena, Vangelis G Manolopoulos, Cristina Rodriguez-Antona, Sanja Stankovic, Ron H N van Schaik
The need of the clinical implementation of pharmacogenetics in European health services for routine drug prescription. What's next? An urgent clinical unmet need for patients. Drug metabolism and personalized therapy (2020)
Fernando de Andrés, Catalina Altamirano-Tinoco, Ronald Ramírez-Roa, Carlos F Montes-Mondragón, Pedro Dorado, Eva M Peñas-Lledó, Adrián LLerena
Relationships between CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4 metabolic phenotypes and genotypes in a Nicaraguan Mestizo population. The pharmacogenomics journal 21 (2) (2020)
Alba P Sarmiento, Pedro Dorado, Angélica Borbón, Fernando de Andrés, Adrián LLerena, null null
High prevalence of CYP2D6 ultrarapid metabolizers in a mestizo Colombian population in relation to Hispanic mestizo populations. Pharmacogenomics 21 (17) (2020)

Adrián LLerena.css-eqlu8i{font-size:small;padding-left:4px;} (Adrián Llerena, Adrian Llerena)

Publication Activity (10 Years)

Top Topics

Top Venues

Adrián LLerena (Adrián Llerena, Adrian Llerena)